At FutuRx we transform science into therapeutic breakthroughs.
FutuRx was founded by Johnson & Johnson Innovation – JJDC , Takeda Pharmaceutical Company, through its venture group Takeda Ventures Inc.-TVI and OrbiMed Israel Partners together with the Israeli Innovation Authority of the Ministry of Economy and later joined by Leaps by Bayer , the impact investments unit of Bayer AG.
The FutuRx incubator is dedicated to the inception of early-stage biopharma ventures based on cutting edge science and supporting them in successful drug development.